Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
2228321-98-8
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Amgen
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tarlatamab
|
| gptkbp:macromoleculeType |
gptkb:Delta-like_ligand_3
|
| gptkbp:mechanismOfAction |
bispecific T-cell engager
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:synonym |
gptkb:AMG_757
|
| gptkbp:target |
gptkb:DLL3
|
| gptkbp:UNII |
1Q1Q1Q1Q1Q
|
| gptkbp:usedFor |
Small Cell Lung Cancer
|
| gptkbp:bfsParent |
gptkb:Non-Small_Cell_Lung_Cancer
|
| gptkbp:bfsLayer |
6
|